Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Rodríguez García, María I ^a   Monserrat, Lorenzo ^a   Ortiz, Martín ^a   Fernández, Xusto ^a   Cazón, Laura ^a   Núñez, Lucía ^a   Barriales Villa, Roberto ^a   Maneiro, Emilia ^a   Veira, Elena ^a   Castro Beiras, Alfonso ^a   Hermida Prieto, Manuel ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALANINE; ARGININE; ASPARAGINE; ASPARTIC ACID; GLUTAMIC ACID; GLUTAMINE; GUANINE; LYSINE; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; PROLINE; PROTEIN MYBPC3; PROTEIN MYH7; SERINE; THREONINE; TRYPTOPHAN; UNCLASSIFIED DRUG; VALINE; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C;

ADULT; AGE; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PREVALENCE; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; ALTERNATIVE RNA SPLICING; AMINO ACID SUBSTITUTION; FAMILY; GENETICS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; MUTATION; PEDIGREE; PHENOTYPE;

ADULT; ALTERNATIVE SPLICING; AMINO ACID SUBSTITUTION; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CARRIER STATE; COHORT STUDIES; FAMILY; GENOTYPE; HOMOZYGOTE; HUMANS; MUTATION; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 77951549322     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-67     Document Type: Article

References (35)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED, . Task Force on Clinical Expert Consensus Documents American College of Cardiology; Committee for Practice Guidelines European Society of Cardiology American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003, 24:1965-1991. 10.1016/S0195-668X(03)00479-2, 14585256, Task Force on Clinical Expert Consensus Documents American College of Cardiology; Committee for Practice Guidelines European Society of Cardiology American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy.
2. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuwelt S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008, 29:270-276. 10.1093/eurheartj/ehm342, 17916581.
3. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell 1990, 62:999-1006. 10.1016/0092-8674(90)90274-I, 1975517.
4. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995, 11:434-437. 10.1038/ng1295-434, 7493025.
5. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001, 104:557-567. 10.1016/S0092-8674(01)00242-2, 11239412.
6. Arad M, Penas-Lado M, Monserrat L, Maron BJ, Sherrid M, Ho CY, Barr S, Karim A, Olson TM, Kamisago M, Seidman JG, Seidman CE. Gene Mutations in Apical Hypertrophic Cardiomyopathy. Circulation 2005, 112:2805-2811. 10.1161/CIRCULATIONAHA.105.547448, 16267253.
7. Lind JM, Chiu C, Semsarian C. Genetic basis of hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther 2006, 4:927-934. 10.1586/14779072.4.6.927, 17173506.
8. Winegrad S. Cardiac myosin binding protein C. Circ Res 1999, 84:1117-1126.
9. Flashman E, Redwood C, Moolman-Smook J, Watkins H. Cardiac Myosin Binding Protein C: Its role in Physiology and Disease. Circ Res 2004, 94:1279-1289. 10.1161/01.RES.0000127175.21818.C2, 15166115.
10. Laredo R, Monserrat L, Hermida-Prieto M, Fernández X, Rodríguez I, Cazón L, Alvariño I, Dumont C, Piñón P, Peteiro J, Bouzas B, Castro-Beiras A. Beta-Myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 2006, 59:1008-1018. 10.1157/13093977, 17125710.
11. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna WJ, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998, 338:1248-1257. 10.1056/NEJM199804303381802, 9562578.
12. Fokstuen S, Lyle R, Munoz A, Gehrig C, Lerch R, Perrot A, Osterziel KJ, Geier C, Beghetti M, Mach F, Sztajzel J, Sigwart U, Antonarakis SE, Blouin JL. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Hum Mutat 2008, 29:879-885. 10.1002/humu.20749, 18409188.
13. Garcia-Castro M, Coto E, Reguero J, Berrazueta JR, Alvarez V, Alonso B, Sainz R, Martin M, Moris C. Espectro mutacional de los genes sarcomericos MYH7, MYBPC3, TNNT2, TNNI3 y TPM1 en pacientes con miocardiopatia hipertrofica. Rev Esp Cardiol 2009, 62:48-56. 10.1016/S1885-5857(09)71513-0, 19150014.
14. Carrier L, Bonne G, Bahrend E, Yu B, Richard P, Niel F, Hainque B, Cruard C, Gary F, Labiet S, Bouhour JB, Dubourg O, Desnos M, Hagege A, Trent RJ, Komajga M, Fiszman M, Schwartz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997, 80:427-434.
15. Ehlermann P, Weichenhan D, Zehelein J, Steen H, Pribe R, Zeller R, Lehrke S, Zugck C, Ivandic BT, Katus HA. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene. BMC Med Genet 2008, 9:95. 10.1186/1471-2350-9-95, 2584029, 18957093.
16. Brito D, Madeira H. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?. Rev Port Cardiol 2005, 24:1137-1146.
17. Brion M, Allegue C, Gil R, Torres M, Santori M, Poster S, Madea B, Carracedo A. Involvement of hypertrophic cardiomyopathy genes in sudden infant death syndrome (SIDS). Forensic Sci Int: Genet Suppl 2009, 2:495-496.
18. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. EUROGENE Heart Failure Project Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003, 107:2227-2232. 10.1161/01.CIR.0000066323.15244.54, 12707239.
19. Ortiz M, Rodriguez-Garcia MI, Hermida-Prieto M, Fernández X, Veira E, Barriales-Villa R, Castro-Beiras A, Monserrat L. Mutación en homocigosis en el gen MYBPC3 asociada a fenotipos severos y alto riesgo de muerte súbita en una familia con miocardiopatía hipertrófica. Rev Esp Cardiol 2009, 62:572-575. 10.1016/S1885-5857(09)71841-9, 19406073.
20. Andersen PS, Havndrup O, Bundgaard H, Larsen LA, Vuust J, Pedersen AK, Kjeldsen K, Christiansen M. Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency. Eur J Hum Genet 2004, 12:673-677. 10.1038/sj.ejhg.5201190, 15114369.
21. Cardim N, Perrot A, Santos S, Morgado P, Padua M, Ferreira S, Reis RP, Monteiro C, Ferreira T, Correia JM, Osterziel KJ. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. Rev Port Cardiol 2005, 24:1463-1476.
22. Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, Semsarian C. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 2005, 42:e59. 10.1136/jmg.2005.033886, 1735926, 16199542.
23. Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E, Ommen SR, Theis JL, Vaubel RA, Re F, Armentano C, Poggesi C, Torricelli F, Cecchi F. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clinic Proceedings 2008, 83:630-638. 10.4065/83.6.630, 18533079.
24. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 44:1903-1910. 10.1016/j.jacc.2004.07.045, 15519027.
25. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 2005, 80:463-469. 10.4065/80.4.463, 15819282.
26. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K. Familial Hypertrophic Cardiomyopathy: From Mutations to Functional Defects. Circ Res 1998, 83:580-593.
27. Erdmann J, Raible J, Maki-Abadi J, Hummel M, Hammann J, Wollnik B, Frantz E, Fleck E, Hetzer R, Regitz-Zagrosek V. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol 2001, 38:322-330. 10.1016/S0735-1097(01)01387-0, 11499719.
28. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest 1998, 102:1292-1300. 10.1172/JCI3880, 508976, 9769321.
29. McConnell BK, Fatkin D, Semsarian C, Jones KA, Georgakopoulos D, Maguire CT, Healey MJ, Mudd JO, Moskowitz IP, Conner DA, Giewat M, Wakimoto H, Berul CI, Schoen FJ, Kass DA, Seidman CE, Seidman JG. Comparison of two murine models of familial hypertrophic cardiomyopathy. Circulation Research 2001, 88:383-389.
30. Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, Greaser ML, Powers PA, Moss RL. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circulation Research 2002, 90:594-601. 10.1161/01.RES.0000012222.70819.64, 11909824.
31. Nanni L, Pieroni M, Chimenti C, Simionati B, Zimbello R, Maseri A, Frustaci A, Lanfranchi G. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. Biochem Biophys Res Commun 2003, 309:391-398. 10.1016/j.bbrc.2003.08.014, 12951062.
32. Charron P, Dubourg O, Desnos M, Bennaceur M, Carrier L, Camproux AC, Isnard R, Hagege A, Langlard JM, Bonne G, Richard P, Hainque B, Bouhour JB, Schwartz K, Komajda M. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 1998, 97:2230-2236.
33. Charron P, Dubourg O, Desnos M, Bouhour JB, Isnard R, Hagege A, Carrier L, Bonne G, Tesson F, Richard P, Hainque B, Schwartz K, Komajda M. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J 1998, 19:1377-1382. 10.1053/euhj.1998.1049, 9792264.
34. Flavigny J, Souchet M, Sebillon P, Berrebi-Bertrand I, Uainque B, Maller A, Bril A, Schwartz K, Carrier L. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J Mol Biol 1999, 94:443-456.
35. Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 2008, 358:1899-1908. 10.1056/NEJMoa075463, 2752150, 18403758.